(Q38444089)

3 September 2017

title

Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization (English)

1 reference

3 September 2017

1 reference

Alaa M Afify

1

1 reference

3 September 2017

Robert Stern

series ordinal

2

1 reference

3 September 2017

Claire W Michael

series ordinal

3

1 reference

3 September 2017

language of work or name

1 reference

1 March 2005

1 reference

3 September 2017

published in

Diagnostic Cytopathology

1 reference

3 September 2017

volume

32

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

145-150

1 reference

The hyaluronic acid binding region as a specific probe for the localization of hyaluronic acid in tissue sections. Application to chick embryo and rat brain

3 September 2017

cites work

1 reference

Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors

21 January 2018

1 reference

Hyaluronate and invasiveness of the rabbit V2 carcinoma

21 January 2018

1 reference

7 January 2021

Serum hyaluronan (hyaluronic acid) in breast cancer patients

1 reference

7 January 2021

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

1 reference

7 January 2021

Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding proteins from cartilage

1 reference

7 January 2021

Age-dependent changes of hyaluronan in human skin

1 reference

7 January 2021

Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma

1 reference

7 January 2021

Distinction between cells in serous effusions using a panel of antibodies

1 reference

7 January 2021

Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma

1 reference

7 January 2021

Calretinin: A Novel Immunocytochemical Marker for Mesothelioma

1 reference

7 January 2021

Utility of HBME-1 immunostaining in serous effusions

1 reference

7 January 2021

Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma

1 reference

7 January 2021

Multiple peritoneal cytologies collected during laparotomy for gynecologic malignancy

1 reference

7 January 2021

Benign mesothelial proliferation with effusion. Clinicopathologic entity that may mimic malignancy

1 reference

7 January 2021

A comparison of different methods of detecting mucin in adenocarcinomas of the lung

1 reference

7 January 2021

Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining

1 reference

7 January 2021

The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and mi

1 reference

7 January 2021

Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases

1 reference

7 January 2021

A novel biotinylated probe specific for hyaluronate. Its diagnostic value in diffuse malignant mesothelioma

1 reference

7 January 2021

Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma

1 reference

7 January 2021

Cell aggregation: role of acid mucopolysaccharides

1 reference

7 January 2021

Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings

1 reference

7 January 2021

CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma

1 reference

7 January 2021

Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura

1 reference

7 January 2021

Analysis of CD44 expression in serous and mucinous borderline tumours of the ovary: comparison with cystadenomas and overt carcinomas

1 reference

7 January 2021

Soluble CD44 splice variants in metastasizing human breast cancer

1 reference

7 January 2021

Identifiers

DOI

10.1002/DC.20201

1 reference

3 September 2017

1 reference